Literature DB >> 34187598

Circular RNA circRHOBTB3 is downregulated in hepatocellular carcinoma and suppresses cell proliferation by inhibiting miR-18a maturation.

Gang Hu1, Shusen Zhai2, Sheng Yu3, Zhen Huang1, Ran Gao1.   

Abstract

BACKGROUND: Circular RNA circRHOBTB3 has been characterized as a tumor suppressor in gastric cancer, while its role in hepatocellular carcinoma (HCC) is unknown. This study was carried out to analyze the role of circRHOBTB3 in HCC.
METHODS: In this study, circRHOBTB3, mature miR-18a, and miR-18a precursor in HCC and paired non-cancer tissues were detected by RT-qPCR. The role of circRHOBTB3 in the production of mature miR-18a was explored by transfecting circRHOBTB3 expression vector into HCC cells, followed by RT-qPCR to determine the expression of mature miR-18a and miR-18a precursor. The role of circRHOBTB3 and miR-18a in HCC cell proliferation was studied using CCK-8 assay.
RESULTS: CircRHOBTB3 was under-expressed in HCC compared to normal tissues. In HCC cells, circRHOBTB3 overexpression decreased mature miR-18a level but not miR-18a precursor. Cell proliferation analysis showed that circRHOBTB3 overexpression decreased cell proliferation while miR-18a overexpression increased cell proliferation. Moreover, circRHOBTB3 suppressed the role of miR-18a in cell proliferation.
CONCLUSIONS: CircRHOBTB3 is downregulated in HCC and may suppress cell proliferation by reducing miR-18a production.

Entities:  

Keywords:  Hepatocellular carcinoma; Precursor; circRHOBTB3; miR-18a

Year:  2021        PMID: 34187598     DOI: 10.1186/s13027-021-00384-1

Source DB:  PubMed          Journal:  Infect Agent Cancer        ISSN: 1750-9378            Impact factor:   2.965


  18 in total

Review 1.  Targeted therapy of hepatocellular carcinoma: present and future.

Authors:  Stephen L Chan; Winnie Yeo
Journal:  J Gastroenterol Hepatol       Date:  2012-05       Impact factor: 4.029

Review 2.  Circular RNAs and cancer.

Authors:  Jun He; Qichao Xie; Hailin Xu; Jiantian Li; Yongsheng Li
Journal:  Cancer Lett       Date:  2017-03-22       Impact factor: 8.679

Review 3.  Global Epidemiology of Hepatocellular Carcinoma (HCC Epidemiology).

Authors:  Aysegul Ozakyol
Journal:  J Gastrointest Cancer       Date:  2017-09

Review 4.  Hepatocellular carcinoma: A global view.

Authors:  Ju Dong Yang; Lewis R Roberts
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-07-13       Impact factor: 46.802

Review 5.  Molecularly targeted therapy in hepatocellular carcinoma.

Authors:  Hung Huynh
Journal:  Biochem Pharmacol       Date:  2010-04-04       Impact factor: 5.858

Review 6.  Epigenetic mechanism involved in the HBV/HCV-related hepatocellular carcinoma tumorigenesis.

Authors:  Liang Rongrui; Huang Na; Li Zongfang; Ji Fanpu; Jiang Shiwen
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

7.  Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration.

Authors:  Rosa Zampino; Maria A Pisaturo; Grazia Cirillo; Aldo Marrone; Margherita Macera; Luca Rinaldi; Maria Stanzione; Emanuele Durante-Mangoni; Ivan Gentile; Evangelista Sagnelli; Giuseppe Signoriello; Emanuele Miraglia Del Giudice; Luigi E Adinolfi; Nicola Coppola
Journal:  Ann Hepatol       Date:  2015 Jan-Feb       Impact factor: 2.400

Review 8.  Hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC): molecular mechanisms and novel paradigms.

Authors:  C Brechot; D Kremsdorf; P Soussan; P Pineau; A Dejean; P Paterlini-Brechot; P Tiollais
Journal:  Pathol Biol (Paris)       Date:  2010-07-27

Review 9.  circRNAs in Cancer.

Authors:  Ines Lucia Patop; Sebastian Kadener
Journal:  Curr Opin Genet Dev       Date:  2017-12-12       Impact factor: 5.578

Review 10.  Hepatitis B and C virus infection and hepatocellular carcinoma in China: a review of epidemiology and control measures.

Authors:  Masahiro Tanaka; Francisco Katayama; Hideaki Kato; Hideo Tanaka; Jianbing Wang; You Lin Qiao; Manami Inoue
Journal:  J Epidemiol       Date:  2011-10-22       Impact factor: 3.211

View more
  2 in total

1.  The molecular mechanism of circRHOBTB3 inhibits the proliferation and invasion of epithelial ovarian cancer by serving as the ceRNA of miR-23a-3p.

Authors:  Yihan Fu; Hong Sun
Journal:  J Ovarian Res       Date:  2022-06-01       Impact factor: 5.506

2.  Tumor-suppressive circRHOBTB3 is excreted out of cells via exosome to sustain colorectal cancer cell fitness.

Authors:  Chaoyi Chen; Hongfei Yu; Fengyan Han; Xuan Lai; Kehong Ye; Siqin Lei; Minglang Mai; Maode Lai; Honghe Zhang
Journal:  Mol Cancer       Date:  2022-02-11       Impact factor: 27.401

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.